openPR Logo
Press release

Pharmaceutical Intermediate Market 2023: Some Basic Influencing Factors Making It's Booming Industry | Lonza, Catalent, Patheon N.V, Jubilant Ingrevia, Ganesh Chemical

09-07-2023 11:23 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Exactitude Consultancy Reports 2023

Exactitude Consultancy Reports 2023

In a recently released analysis titled "Pharmaceutical Intermediate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," Exactitude Consultancy, a reputable market research firm, provided data. The report offers a thorough overview of the market, including data on market size, trends, and growth projections for the global Pharmaceutical Intermediate market. The study highlights the most recent developments in the industry and provides competitor and geographical analysis.

"The Global Pharmaceutical Intermediates Market is expected to grow at more than 7.3% CAGR from 2021 to 2026. It is expected to reach above USD 73 billion by 2026 from a little above USD 48 billion in 2020."

The global demand for drug development intermediates for treating chronic diseases is driven by the increasing prevalence of chronic diseases and the growing geriatric population. Diabetes is a major cause of stroke, heart attacks, and kidney failure, and the geriatric population is expected to reach 2 million by 2050. Investments and government support in developed nations like the US contribute to the growth of the biopharmaceutical industry.

Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/1793/pharmaceutical-intermediate-market/#request-a-sample

**Note - Updated Version 2023 is available

What this report provides?

The research provides a comprehensive overview of the current state of the Pharmaceutical Intermediate market and its anticipated future evolution.

Key companies manufacturing Pharmaceutical Intermediate worldwide are profiled, providing an overview of their financials, product portfolio, recent developments, and future outlook.

The report evaluates the current opportunity and future growth potential of the Pharmaceutical Intermediate market, providing estimates for its mid-to-long term evolution during the forecast period 2023-2026, aiming to identify potential trends and opportunities.

Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-over-year growth, competitive benchmarking, vendor identification, CMI quadrant, and other significant analysis, as well as development status.

Recent market trends and its potential for future growth
regional reports that can be customised upon request

Who are the major players in this industry?

Lonza, Catalent, Patheon N.V, Jubilant Ingrevia, Ganesh Chemical, Chemcon, BASF, Lianhetech, ABA Chem, Porton, Jiansu Jiu Technology, and Tianma, and others.

Recent Developments in Pharmaceutical Intermediate Market

Recent developments in Pharmaceutical Intermediate industry, even after market report release, support market trends outlined in analysis.

In March 2022, Sumitomo Chemical Co., Ltd. announced that it will construct a new manufacturing plant for active pharmaceutical ingredients (APIs) and intermediates for small molecule drugs at its Oita Works (Oita City, Oita Prefecture, Japan). This project is to enhance the Company's capacity to supply a variety of high-quality APIs and intermediates in response to the increasing demand for small-molecule drugs.

In October 2022, AstraZeneca's Imjudo (tremelimumab) in combination with Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with unresectable hepatocellular carcinoma (HCC), the most common type of liver cancer.

In February 2022, three manufacturing facilities have been purchased by CordenPharma from Vifor Pharma. These facilities will eventually be renamed Corden Pharma Fribourg S.A. in Switzerland (with its branch in Ettingen) and Corden Pharma Lisbon S.A. in Portugal.

What exactly does market segmentation cover?

Pharmaceutical Intermediates Market by Type, 2019-2026, (In USD Million)

GMP

Non GMP

Pharmaceutical Intermediates Market by Applications, 2019-2026, (In USD Million)

Antibiotic

Antipyeritic Analgesics

Vitamins

Other

Regional Analysis of the Pharmaceutical Intermediate Market

The market development, current market trends, and some research methodologies are all covered in the Pharmaceutical Intermediate Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.

Key Geographical Regions

North America (US, Canada)
Europe (Germany, UK, France, Italy, Spain)
Asia-Pacific (China, Australia, Japan)
Middle East and North Africa
Latin America

Table of Content:

1 Study Reporting
1.1 Pharmaceutical Intermediate Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Pharmaceutical Intermediate Market Size Growth Rate by Type
1.5 Market by Application

2 Executive Instantaneous
2.1 Global Pharmaceutical Intermediate Market Size
2.1.1 Global Pharmaceutical Intermediate Revenue
2.1.2 Global Pharmaceutical Intermediate Production
2.2 Pharmaceutical Intermediate Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Pharmaceutical Intermediate Manufacturers
2.3.2.1 Pharmaceutical Intermediate Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Pharmaceutical Intermediate Product Offered
2.3.2.3 Date of Manufacturers Enter into Pharmaceutical Intermediate Market
2.4 Key Trends for Pharmaceutical Intermediate Markets & Products

3 Market Size by Manufacturers
3.1 Pharmaceutical Intermediate Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Intermediate Production by Regions

4.1 Global Pharmaceutical Intermediate Production by Regions
4.1.1 Global Pharmaceutical Intermediate Production Market Share by Regions
4.1.2 Global Pharmaceutical Intermediate Revenue Market Share by Regions
4.2 United States
4.2.1 United States Pharmaceutical Intermediate Production
4.2.2 United States Pharmaceutical Intermediate Revenue
4.2.3 Key Players in United States
4.2.4 United States Pharmaceutical Intermediate Import & Export
4.3 Europe
4.3.1 Europe Pharmaceutical Intermediate Production
4.3.2 Europe Pharmaceutical Intermediate Revenue

5 Pharmaceutical Intermediate Consumption by Regions

5.1 Global Pharmaceutical Intermediate Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country

6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type

7 Market Size by Application
7.1 Overview
7.2 Global Pharmaceutical Intermediate Breakdown Dada by Application
7.2.1 Global Pharmaceutical Intermediate Consumption by Application
7.2.2 Global Pharmaceutical Intermediate Consumption Market Share by Application

8 Manufacturers Profiles
9 Production Forecasts
9.1 Pharmaceutical Intermediate Production and Revenue Forecast
9.1.1 Global Pharmaceutical Intermediate Production Forecast
9.1.2 Global Pharmaceutical Intermediate Revenue Forecast
9.2 Pharmaceutical Intermediate Production and Revenue Forecast by Regions
9.2.1 Global Pharmaceutical Intermediate Revenue Forecast by Regions
9.2.2 Global Pharmaceutical Intermediate Production Forecast by Regions
9.3 Pharmaceutical Intermediate Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Pharmaceutical Intermediate Production Forecast by Type
9.4.2 Global Pharmaceutical Intermediate Revenue Forecast by Type

10 Consumption Forecast
10.1 Pharmaceutical Intermediate Consumption Forecast by Application
10.2 Pharmaceutical Intermediate Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Pharmaceutical Intermediate Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Pharmaceutical Intermediate Consumption Forecast by Regions
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Pharmaceutical Intermediate Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Pharmaceutical Intermediate Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Pharmaceutical Intermediate Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Pharmaceutical Intermediate Sales Channels
11.2.2 Pharmaceutical Intermediate Distributors
11.3 Pharmaceutical Intermediate Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Key Findings in the Global Pharmaceutical Intermediate Study

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Continue….

Get a Sample Copy of the Pharmaceutical Intermediate Market Research Report (Use Corporate mail id for quick response)-@https://exactitudeconsultancy.com/reports/1793/pharmaceutical-intermediate-market/#request-a-sample

Customization Service of the Report:

Exactitude Consultancy offers personalized reports tailored to your specific needs, with a sales team dedicated to ensuring you receive a report that meets your specific requirements.

Research Methodology

The report is based on data analysis strategies by skilled data analysts. The research methodology involves collecting and analyzing information to provide significant market predictions. Interviews with market influencers make primary research relevant and practical. The secondary method provides a direct insight into demand and supply. Both primary and secondary data collection methods are used, along with publicly available sources like annual reports and white papers, to provide a comprehensive understanding of the market. The report offers precise data analysis and a comprehensive market tour.

Healthcare Trending Reports

https://www.openpr.com/news/3199662/green-and-bio-solvents-market-size-to-generate-usd-2-55-billion

https://www.openpr.com/news/3199685/physiotherapy-equipment-market-surveying-report-drivers

https://www.openpr.com/news/3199718/point-of-care-diagnostics-market-to-witness-huge-growth-by-2028

https://www.openpr.com/news/3199735/medical-composites-market-to-witness-huge-growth-by-key-players

About Us

Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Connect Us:

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Intermediate Market 2023: Some Basic Influencing Factors Making It's Booming Industry | Lonza, Catalent, Patheon N.V, Jubilant Ingrevia, Ganesh Chemical here

News-ID: 3199803 • Views:

More Releases from Exactitude Consultancy

Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation. The global Huntington's Disease market is poised for strong
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide. For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billion by 2034
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619 The
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity Ahead
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide. FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the